PA
UGP icon

PharVision Advisers’s Ultrapar UGP Stock Holding History

PharVision Advisers’s Portfolio UGP Stock Details UGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
20,690
+6,167
+42% +$33.9K 1.96% 16
2026
Q1 		$80K Sell
14,523
-37,357
-72% -$181K 0.81% 64
2025
Q4 		$196K Buy
51,880
+23,498
+83% +$92.9K 0.1% 566
2025
Q3 		$116K Buy
+28,382
New +$96.5K 0.07% 609

Other funds holding UGP

NC
Naman Capital Sao Paulo, Brazil $323M AUM 37.1% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's UGP Position: Q2 2026 in Review

PharVision Advisers increased its Ultrapar (UGP) stake by 42% in Q2 2026, buying an estimated $33.9K and bringing the position to 20,690 shares worth $104K. The position accounts for 1.96% of the portfolio, ranked #16.

PharVision Advisers first reported a position in UGP in Q3 2025 and has held it in 4 quarters since. The position peaked at $196K in Q4 2025. 178 funds tracked by Wall St. Rank hold UGP as of Q2 2026.

  • PharVision Advisers held 20,690 shares of Ultrapar worth $104K as of Q2 2026.
  • PharVision Advisers bought 6,167 Ultrapar shares in Q2 2026, an estimated $33.9K.
  • Ultrapar made up 1.96% of PharVision Advisers's portfolio in Q2 2026, its #16 holding.
  • PharVision Advisers first reported a position in Ultrapar in Q3 2025 and has held it in 4 quarters since.
  • PharVision Advisers's Ultrapar position peaked at $196K in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Ultrapar as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.